Applied Therapeutics, Inc.
APLTDelisted Feb 3, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001697532
Applied Therapeutics, Inc. was delisted on Feb 3, 2026; its insiders filed their last Form 4 on Feb 4, 2026; 52 institutions reported holding it in 13F filings for Q4 2025, worth $5.93M in total; no superinvestor held it.
Q3 2021 vs. Q2 2021
How the institutions holding Applied Therapeutics, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 69 | 70 | +1 |
| Shares | 15.4M | 15.1M | −258.5K (−1.7%) |
| Value | $319.3M | $250.9M | −$68.4M (−21.4%) |
New holders (8)
Institutions that held Applied Therapeutics, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Millennium Management LLC | 11,933 | $198.0K | 0.00% |
| Squarepoint Ops LLC | 10,700 | $178.0K | 0.00% |
| Two Sigma Advisers, LP | 10,400 | $173.0K | 0.00% |
| SG Americas Securities, LLC | 9,202 | $153.0K | 0.00% |
| Cubist Systematic Strategies, LLC | 4,019 | $67.0K | 0.00% |
| Point72 Hong Kong Ltd | 605 | $10.0K | 0.00% |
| US Bancorp | 103 | $2.00K | 0.00% |
| Parallel Advisors, LLC | 90 | $1.00K | 0.00% |
Sold out (7)
Institutions that held Applied Therapeutics, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Bamco Inc | 237,800 | $4.94M |
| Stifel Financial Corp | 132,596 | $2.75M |
| DSAM Partners (London) Ltd | 67,125 | $1.40M |
| Citadel Advisors LLC | 13,119 | $273.0K |
| DekaBank Deutsche Girozentrale | 7,000 | $150.0K |
| Nisa Investment Advisors, LLC | 2,000 | $42.0K |
| Ellevest, Inc. | 48 | $1.00K |